Intravesical therapies for bladder cancer - indications and limitations
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Intravesical therapies for bladder cancer - indications and limitations
Authors
Keywords
-
Journal
BJU INTERNATIONAL
Volume 110, Issue -, Pages 12-21
Publisher
Wiley
Online
2012-11-30
DOI
10.1111/j.1464-410x.2012.11619.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Intravesical gemcitabine therapy for non-muscle invasive bladder cancer (NMIBC): a systematic review
- (2012) Mike D. Shelley et al. BJU INTERNATIONAL
- EAU Guidelines on Non–Muscle-Invasive Urothelial Carcinoma of the Bladder, the 2011 Update
- (2011) Marko Babjuk et al. EUROPEAN UROLOGY
- Apaziquone as an intravesical therapeutic agent for urothelial non-muscle-invasive bladder cancer
- (2011) Vladimir Yutkin et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Electromotive instillation of mitomycin immediately before transurethral resection for patients with primary urothelial non-muscle invasive bladder cancer: a randomised controlled trial
- (2011) Savino M Di Stasi et al. LANCET ONCOLOGY
- Failure of bacille Calmette-Guérin in patients with high risk non-muscle-invasive bladder cancer unsuitable for radical cystectomy: an update of available treatment options
- (2010) David R. Yates et al. BJU INTERNATIONAL
- Gemcitabine versus bacille Calmette-Guérin after initial bacille Calmette-Guérin failure in non-muscle-invasive bladder cancer
- (2010) Giuseppe Di Lorenzo et al. CANCER
- Is gemcitabine an option in BCG-refractory nonmuscle-invasive bladder cancer? A single-arm prospective trial
- (2009) Sisto Perdonà et al. ANTI-CANCER DRUGS
- Cost-effectiveness analysis of immediate radical cystectomy versus intravesicalBacillusCalmette-Guerin therapy for high-risk, high-grade (T1G3) bladder cancer
- (2009) Girish S. Kulkarni et al. CANCER
- Single Postoperative Instillation of Gemcitabine in Patients with Non-muscle-invasive Transitional Cell Carcinoma of the Bladder: A Randomised, Double-blind, Placebo-controlled Phase III Multicentre Study
- (2009) Andreas Böhle et al. EUROPEAN UROLOGY
- Should All Patients with Non–Muscle-Invasive Bladder Cancer Receive Early Intravesical Chemotherapy after Transurethral Resection? The Results of a Prospective Randomised Multicentre Study
- (2009) Sigurdur Gudjónsson et al. EUROPEAN UROLOGY
- An Individual Patient Data Meta-Analysis of the Long-Term Outcome of Randomised Studies Comparing Intravesical Mitomycin C versus Bacillus Calmette-Guérin for Non–Muscle-Invasive Bladder Cancer
- (2009) Per-Uno Malmström et al. EUROPEAN UROLOGY
- Detrusor Muscle in the First, Apparently Complete Transurethral Resection of Bladder Tumour Specimen Is a Surrogate Marker of Resection Quality, Predicts Risk of Early Recurrence, and Is Dependent on Operator Experience
- (2009) Paramananthan Mariappan et al. EUROPEAN UROLOGY
- Randomized Phase III Trial on Gemcitabine Versus Mytomicin in Recurrent Superficial Bladder Cancer: Evaluation of Efficacy and Tolerance
- (2009) Raffaele Addeo et al. JOURNAL OF CLINICAL ONCOLOGY
- Combined Thermo-Chemotherapy for Recurrent Bladder Cancer After Bacillus Calmette-Guerin
- (2009) Ofer Nativ et al. JOURNAL OF UROLOGY
- Sequential intravesical gemcitabine and mitomycin C chemotherapy regimen in patients with non-muscle invasive bladder cancer
- (2009) Benjamin N. Breyer et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Two-year follow-up of the phase II marker lesion study of intravesical apaziquone for patients with non-muscle invasive bladder cancer
- (2009) Kees Hendricksen et al. WORLD JOURNAL OF UROLOGY
- Intravesical hyperthermia and mitomycin-C for carcinoma in situ of the urinary bladder: experience of the European Synergo® working party
- (2009) J. Alfred Witjes et al. WORLD JOURNAL OF UROLOGY
- Safety and Side Effects of Immediate Instillation of Apaziquone Following Transurethral Resection in Patients With Nonmuscle Invasive Bladder Cancer
- (2008) K. Hendricksen et al. JOURNAL OF UROLOGY
- Intravesicle gemcitabine in management of BCG refractory superficial TCC of urinary bladder—our experience
- (2008) Nayan Kumar Mohanty et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now